Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 203

1.

Chemoradiotherapy versus chemotherapy alone for unresected intrahepatic cholangiocarcinoma: practice patterns and outcomes from the national cancer data base.

Verma V, Kusi Appiah A, Lautenschlaeger T, Adeberg S, Simone CB 2nd, Lin C.

J Gastrointest Oncol. 2018 Jun;9(3):527-535. doi: 10.21037/jgo.2018.01.15.

2.

Exploratory analysis using machine learning to predict for chest wall pain in patients with stage I non-small-cell lung cancer treated with stereotactic body radiation therapy.

Chao HH, Valdes G, Luna JM, Heskel M, Berman AT, Solberg TD, Simone CB 2nd.

J Appl Clin Med Phys. 2018 Jul 10. doi: 10.1002/acm2.12415. [Epub ahead of print]

PMID:
29992732
3.

Acute Hospital Encounters in Cancer Patients Treated With Definitive Radiation Therapy.

Marar M, Gabriel P, Hwang WT, Owen DR, Ju M, Simone CB 2nd, Christodouleas J, Vapiwala N, Berman AT.

Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):935-944. doi: 10.1016/j.ijrobp.2018.04.025. Epub 2018 Apr 18.

PMID:
29976506
4.

Disparities in Perioperative Radiation Therapy Use in Elderly Patients With Soft-Tissue Sarcoma.

Venigalla S, Carmona R, VanderWalde N, Sebro R, Sharma S, Simone CB 2nd, Wilson RJ 2nd, Weber KL, Shabason JE.

Int J Radiat Oncol Biol Phys. 2018 May 14. pii: S0360-3016(18)30812-5. doi: 10.1016/j.ijrobp.2018.05.019. [Epub ahead of print]

PMID:
29958721
5.

Cardiac mortality in limited-stage small cell lung cancer.

Verma V, Fakhreddine MH, Haque W, Butler EB, Teh BS, Simone CB 2nd.

Radiother Oncol. 2018 Jun 19. pii: S0167-8140(18)30311-6. doi: 10.1016/j.radonc.2018.06.011. [Epub ahead of print]

PMID:
29934110
6.

Use of PET and Other Functional Imaging to Guide Target Delineation in Radiation Oncology.

Verma V, Choi JI, Sawant A, Gullapalli RP, Chen W, Alavi A, Simone CB 2nd.

Semin Radiat Oncol. 2018 Jun;28(3):171-177. doi: 10.1016/j.semradonc.2018.02.001. Review.

PMID:
29933876
7.

Margins and Uncertainties in Radiation Oncology.

Simone CB 2nd, Sawant A.

Semin Radiat Oncol. 2018 Jun;28(3):169-170. doi: 10.1016/j.semradonc.2018.03.001. No abstract available.

PMID:
29933875
8.

Proton beam therapy for malignant pleural mesothelioma.

Badiyan SN, Molitoris JK, Zhu M, Glass E, Diwanji T, Simone CB 2nd.

Transl Lung Cancer Res. 2018 Apr;7(2):189-198. doi: 10.21037/tlcr.2018.04.07. Review.

9.

Particle therapy in non-small cell lung cancer.

Liao Z, Simone CB 2nd.

Transl Lung Cancer Res. 2018 Apr;7(2):141-152. doi: 10.21037/tlcr.2018.04.11. Review.

10.

Proton therapy for small cell lung cancer.

Verma V, Choi JI, Simone CB 2nd.

Transl Lung Cancer Res. 2018 Apr;7(2):134-140. doi: 10.21037/tlcr.2018.04.02. Review.

11.

Utilization of Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma in the United States.

Shaaban SG, Verma V, Choi JI, Shabason J, Sharma S, Glass E, Grover S, Badiyan SN, Simone CB 2nd.

Clin Lung Cancer. 2018 May 5. pii: S1525-7304(18)30101-3. doi: 10.1016/j.cllc.2018.04.019. [Epub ahead of print]

PMID:
29803576
12.

A preclinical model to investigate the role of surgically-induced inflammation in tumor responses to intraoperative photodynamic therapy.

Davis RW 4th, Papasavvas E, Klampatsa A, Putt M, Montaner LJ, Culligan MJ, McNulty S, Friedberg JS, Simone CB 2nd, Singhal S, Albelda SM, Cengel KA, Busch TM.

Lasers Surg Med. 2018 Jul;50(5):440-450. doi: 10.1002/lsm.22934. Epub 2018 May 25.

PMID:
29799130
13.

Symptom control, treatment-induced nausea prophylaxis, and palliative radiation therapy.

Simone CB 2nd.

Ann Palliat Med. 2018 Apr;7(2):E2-E4. doi: 10.21037/apm.2018.05.09. No abstract available.

14.

Public health approaches to palliative care.

Simone CB 2nd.

Ann Palliat Med. 2018 Apr;7(Suppl 2):E1. doi: 10.21037/apm.2018.05.03. No abstract available.

15.

Facility volume and postoperative outcomes for malignant pleural mesothelioma: A National Cancer Data Base analysis.

Verma V, Ahern CA, Berlind CG, Lindsay WD, Grover S, Culligan MJ, Friedberg JS, Simone CB 2nd.

Lung Cancer. 2018 Jun;120:7-13. doi: 10.1016/j.lungcan.2018.03.019. Epub 2018 Mar 21.

PMID:
29748018
16.

Radiologic Pseudoprogression during Anti-PD-1 Therapy for Advanced Non-Small Cell Lung Cancer.

Katz SI, Hammer M, Bagley SJ, Aggarwal C, Bauml JM, Thompson JC, Nachiappan AC, Simone CB 2nd, Langer CJ.

J Thorac Oncol. 2018 Jul;13(7):978-986. doi: 10.1016/j.jtho.2018.04.010. Epub 2018 May 5.

PMID:
29738824
17.

Malignant Peritoneal Mesothelioma: National Practice Patterns, Outcomes, and Predictors of Survival.

Verma V, Sleightholm RL, Rusthoven CG, Koshy M, Sher DJ, Grover S, Simone CB 2nd.

Ann Surg Oncol. 2018 Jul;25(7):2018-2026. doi: 10.1245/s10434-018-6499-1. Epub 2018 May 2.

PMID:
29721724
18.

Spotlight on dabrafenib/trametinib in the treatment of non-small-cell lung cancer: place in therapy.

Weart TC, Miller KD, Simone CB 2nd.

Cancer Manag Res. 2018 Apr 3;10:647-652. doi: 10.2147/CMAR.S142269. eCollection 2018. Review.

19.

Practice patterns and outcomes of chemoradiotherapy versus radiotherapy alone for older patients with nasopharyngeal cancer.

Verma V, Surkar SM, Moreno AC, Lin C, Simone CB 2nd.

Cancer Med. 2018 May;7(5):1604-1611. doi: 10.1002/cam4.1290. Epub 2018 Mar 30.

20.

Breaking the dose ceiling: proton therapy for locally advanced non-small cell lung cancer.

Choi JI, Simone CB 2nd.

J Thorac Dis. 2018 Jan;10(1):130-134. doi: 10.21037/jtd.2017.12.79. No abstract available.

Supplemental Content

Loading ...
Support Center